Ultrastructural and proliferative features of the ventral lobe of the prostate in non-obese diabetic mice (NOD) following androgen and estrogen replacement associated to insulin therapy

Tissue and Cell

Volumn 41, Issue 2, 2009, Pages 119-132

  Favaro W J ^a   Padovani, C R ^b   Cagnon, V H A ^a  

^a UNIVERSITY OF CAMPINAS   (Brazil)

^b SÃO PAULO STATE UNIVERSITY UNESP   (Brazil)

Author keywords

Apoptosis; Diabetes mellitus; Proliferation; Steroid hormones; Ultrastructural; Ventral prostate

Indexed keywords

ANDROGEN; ARACHIS OIL; ESTRADIOL; ESTROGEN; ISOPHANE INSULIN; TESTOSTERONE; TESTOSTERONE CIPIONATE;

ANDROGEN THERAPY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; APOPTOSIS; ARTICLE; BAGG ALBINO MOUSE; CELL ACTIVITY; CELL PROLIFERATION; CELL SECRETION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; DIABETES MELLITUS; ESTROGEN THERAPY; IMMUNOHISTOCHEMISTRY; INSULIN TREATMENT; MALE; MOUSE; NONHUMAN; NONOBESE DIABETIC MOUSE; PROSTATE VENTRAL LOBE;

ARACHIS HYPOGAEA; MUS;

EID: 60749107187     PISSN: 00408166     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tice.2008.09.001     Document Type: Article

References (87)

1. Abate-Shem C., and Shem M.M. Molecular genetics of prostate cancer. Genes Dev. 14 (2000) 2410-2434
2. Alberts S.R., and Blute M.L. Chemoprevention for prostatic carcinoma: the role of flutamide in patients with Prostatic Intraepithelial Neoplasia. Urology 57 (2001) 188-190
3. Anderson L.C. Effects of alloxan diabetes and insulin in vivo on rat parotid gland. Am. J. Physiol. 245 (1983) 431-437
4. Aumüller G., and Ader G. Experimental studies of apocrine secretion in the dorsal prostate ephitelium of the rat. Cell Tissue Res. 198 (1979) 145-158
5. Ballester J., Munoz M.C., Dominguez J., Rigau T., Guinovart J.J., and Rodriguez-Gil J.E. Insulin-dependent diabetes affects testicular function by FSH- and LH-linked mechanisms. J. Androl. 25 (2004) 706-719
6. Basaria S., Muller D.C., Carducci M.A., Egan J., and Dobs A.S. Hyperglycemia and insulin resistance in men with prostate carcinoma who receive androgen-deprivation therapy. Cancer 106 (2006) 581-588
7. Behmer, O.A., Tolosa, E.M.C., Freitas-Neto, A.G., 1976. Manual Para Histologia Normal e Patológica. Edart-Edusp, São Paulo, pp. 225.
8. Bianco J.J., Handelsman D.J., Pedersen J.S., and Risbridger G.P. Direct response of the murine prostate gland and seminal vesicles to estradiol. Endocrinology 143 (2002) 4922-4933
9. Billis A. Sistema genital masculino. In: Bogliolo L. (Ed). Patologia. 6th ed. (2000), Guanabara Koogan, Rio de Janeiro 514-537
10. Cagnon V.H.A., Camargo A.M., Rosa R.M., Fabiani C.R., Padovani C.R., and Martinez F.E. Ultrastructure study of the ventral lobe of the prostate of mice with streptozotocin induced diabetes (C57bl/6j). Tissue Cell 32 (2000) 275-283
11. Caldeira E.J., Camilli J.A., and Cagnon V.H. Stereology and ultrastructure of the salivary glands of diabetic Nod mice submitted to long-term insulin treatment. Anat. Rec. 286 (2005) 930-937
12. Carvalho C.A.F., Camargo A.M., Cagnon V.H.A., and Padovani C.R. Effects of experimental diabetes on the structure and ultrastructure of the coagulating gland of C57BL/6j and NOD mice. Anat. Rec. 270 (2003) 129-136
13. Ciardullo A.V., Daghio M.M., Brunnetti M., Berrini M., Daya G., Feltri G., Novi D., Goldoni C.A., Guerzoni A., Messori A., and Magrini N. Audit of shared-care program for persons with diabetes: baselina na 3 annual follow-ups. Acta Diabetol. 41 (2004) 9-13
14. Conget I. Diagnosis, classification and pathogenesis of diabetes mellitus. Rev. Esp. Cardiol. 55 (2002) 528-538
15. Cornell R.J., Rowley D., Wheller T., Ali N., and Ayala G. Neuroepithelial interactions in prostate cancer are enhanced in the presence of prostatic stroma. Urology 61 (2003) 870-875
16. Cunha G.R., and Matrisian L.M. It's not my fault, blame it on my microenvironment. Differentiation 70 (2002) 469-472
17. Cunha G.R., Hayward S.W., and Wang Y.Z. Role of stroma in carcinogenesis of the prostate. Differentiation 70 (2002) 473-485
18. Cunha G.R., Hayward S.W., Wang Y.Z., and Ricke W.A. Role of the stromal microenvironment in carcinogenesis of the prostate. Int. J. Cancer 107 (2003) 1-10
19. Daubrese J.C., Meunier J., Wilmotte A.S., Luyckx A.S., and Lefebvre P.J. Pituitary-testicular axisin diabetic men with and without impotence sexual. Diabete Metab. 4 (1978) 233-237
20. Davidson D., Bostwick D.G., Qian J., Wollan P.C., Oesterling J.E., Rudders R.A., Siroky M., and Stilmant M. Prostatic intraepithelial neoplasia is a risk factor for adenocarcinoma: predictive accuracy in needle biopsies. J. Urol. 154 (1995) 1295-1299
21. Donjacour A.A., Thomson A.A., and Cunha G.R. FGF-10 plays an essential role in the growth of the fetal prostate. Dev. Biol. 26 (2003) 39-54
22. Ekman P. The prostate as an endocrine organ: androgens and estrogens. Prostate 10 (2000) 14-18
23. Fávaro W.J., and Cagnon V.H. Morphometric and morphological features of the ventral prostate in rats submitted to chronic nicotine and alcohol treatment. Tissue Cell 38 (2006) 311-323
24. Franck-Lissbrant I., Häggström S., and Damber J.E. Testosterone stimulates angiogenesis and vascular regrowth in the ventral prostate in castrated adult rats. Endocrinology 139 (1998) 451-456
25. Garcia-Florez M., Oliveira C.A., and Carvalho H.F. Early effects of estrogen on the rat ventral prostate. Braz. J. Med. Biol. Res. 38 (2005) 487-497
26. Garraway L.A., Lin D., Signoretti S., Waltregny D., Bhattacharya N., and Loda M. Intermediate basal cells of the prostate: in vitro and in vivo characterization. Prostate 55 (2003) 206-218
27. Grossfeld G., Hayward S.W., Tlsty T., and Cunha G.R. The role of stroma in prostatic carcinogenesis. Endocr. Relat. Cancer 5 (1998) 253-270
28. Häggman M.J., Macoska J.A., Wojno K.J., and Oesterling J.E. The relationship between prostatic intraepithelial neoplasia and prostate cancer: critical issues. J. Urol. 158 (1997) 12-22
29. Hammarsten J., and Hogstedt B. Hyperinsulinaemia as a risk factor for developing benign prostatic hyperplasia. Eur. Urol. 39 (2002) 151-158
30. Hayward S., Wang Y., Cao M., Hom Y., Zhang B., Grossfeld G., Sudilovsky D., and Cunha G.R. Malignant transformation in a non-tumorigenic human prostatic epithelial cell line. Cancer Res. 61 (2001) 8135-8142
31. Ho S.M. Prostatic androgen receptor and plasma testosterone levels in streptozotocin-induced diabetic rats. J. Steroid Biochem. Mol. Biol. 38 (1991) 67-72
32. Hsing A.W., Reichardt J.K.V., and Stanczyk F.Z. Hormones and prostate cancer: current perspectives and future directions. Prostate 52 (2001) 213-235
33. Hu Y., Nakagawa Y., Purushotham K.R., and Humphreys-Beher M.G. Functional changes in salivary glands of autoimmune disease-prone NOD mice. Am. J. Physiol. 263 (1992) 607-614
34. Humprhreys-Beher M.G., Yamachika S., Yamamoto H., Maeda N., Nakagawa Y., Peck A.B., and Robinson C.P. Salivary gland changes in the NOD mouse model for Sjögren's syndrome: is there a non-immune genetic trigger?. Eur. J. Morphol. 36 (1998) 247-251
35. Ilic M., Vlajinac H., and Marinkovic J. Case-control study of risk factors for prostate cancer. Br. J. Cancer 74 (1996) 1682-1686
36. Imamov O., Shim G.J., Warner M., and Gustafsson J.A. Estrogen receptor Beta in health and disease. Biol. Reprod. 73 (2005) 866-871
37. Jackson F.L., and Hutson J.C. Altered responses to androgens in diabetic male rats. Diabetes 33 (1984) 819
38. Junqueira L.C.U., Bignolas G., and Brentani R. Picrossirius staining plus polarization microscopy, specific method of collagen detection in tissue section. J. Histochem. 11 (1979) 447-455
39. Kerr J.F., and Searle J. Deletion of cells by apoptosis during castration-induced involution of the rat prostate. Virchows Arch. B: Cell Pathol. 13 (1973) 87-102
40. Kerr J.F., Wyllie A.H., and Currie A.R. Apoptosis: a basic biological phenomenon with wide-ranging implications in tissue kinetics. Br. J. Cancer 26 (1972) 239-257
41. Leav I., Lau K.M., Adams J.A., Mcneal J.E., Taplin M.E., Wang J., Singh H., and Ho S.M. Comparative studies of the estrogen receptors beta and alpha and the androgen receptor in normal human prostate glands, dysplasia, and in primary and metastatic carcinoma. Am. J. Pathol. 159 (2001) 79-92
42. Lin E.Y., and Pollard J.W. Role of infiltrated leucocytes in tumour growth and spread. Br. J. Cancer 90 (2004) 2053-2058
43. Makino S., Kunimoto K., Muraoka Y., Mizushima Y., Katagiri K., and Tochino Y. Breeding of a non-obese, diabetic strain of mice. Exp. Anim. 29 (1980) 1-13
44. Marcelli M., and Cunningham G. Hormonal signaling in prostatic hyperplasia and neoplasia. J. Clin. Endocrinol. Metab. 84 (1999) 3463-3468
45. Marker P.C., Donjacour A.A., Dahiya R., and Cunha G.R. Hormonal cellular and molecular control of cprostatic development. Dev. Biol. 253 (2003) 165-174
46. Mcneal J.E., Stamey T.A., and Hodge K.K. The prostate gland: morphology, pathology, ultrasound anatomy. Monogr. Urol. 9 (1988) 36-54
47. Mcpherson S.J., Ellen S.J., Simpson E.R., Patchev V., Fritzemeier K.H., and Risbridger G.P. Essential role for estrogen receptor beta in stromal-epithelial regulation of prostatic hyperplasia. Endocrinology 148 (2007) 566-574
48. Mokdad A.H. The continuing epidemics of obesity and diabetes in the United States. JAMA 286 (2001) 1195
49. Montgomery D.C. Design and Analysis of Experiments (1991), John Wiley, New York p. 649
50. Naslund M.J., Strandberg J.D., and Coffey D.S. The role of androgens and estrogens in the pathogenesis of experimental nonbacterial prostatitis. J. Urol. 140 (1988) 1049-1053
51. Ohta T., Matsui K., Miyajima K., Sasase T., Masuyama T., Shoda T., Koizumi H., Shinohara M., and Matsushita M. Effect of insulin therapy on renal changes in spontaneously diabetic Torii rats. Exp. Anim. 56 (2007) 355-362
52. Oksaen A. Testicular lesion of streptozotocin diabetic rats. Horm. Res. 6 (1975) 138-144
53. Öztürk Y., Altan V.M., and Yildizoglu-Ari N. Effects of experimental diabetes and insulin on smooth muscle functions. Pharmacol. Rev. 48 (1996) 69-104
54. Prins G.S., Birch L., Habermann H., Chang W.Y., Tebeau C., Putz O., and Bieberich C. Influence of neonatal estrogens on rat prostate development. Reprod. Fertil. Dev. 13 (2001) 241-252
55. Quarrie L.H., Addey C.V., and Wilde C.J. Apoptosis in lactating and involuting mouse mammary tissue demonstrated by nick-end DNA labelling. Cell Tissue Res. 281 (1995) 413-419
56. Rauch F., Polzar B., Stephan H., Zanotti S., Paddenber G.R., and Mannherz H.G. Androgen ablation leads to an upregulation and intranuclear accumulation of deoxyribonuclease I in rat prostate epithelial cells paralleling their apoptotic elimination. J. Cell Biol. 137 (1997) 909-923
57. Ribeiro D.L., Caldeira E.J., Candido E.M., Manzato A.J., Taboga S.R., and Cagnon V.H. Prostatic stromal microenvironment and experimental diabetes. Eur. J. Histochem. 50 (2006) 51-60
58. Risbridger G.P., Bianco J.J., Ellem S.J., and Mcpherson S.J. Oestrogens and prostate cancer. Endocr. Relat. Cancer 10 (2003) 187-191
59. Rowley D.R. What might a stromal response mean to prostate cancer progression?. Cancer Metastasis Rev. 76 (1998) 69-125
60. Saito M., Nishi K., Foster-Junior H.E., Weiss R.M., and Latifpour J. Effect of experimental diabetes on rat prostate endothelin receptors. Eur. J. Pharm. 310 (1996) 197-200
61. Santti R.S., and Johanson R. Some biochemical effects of insulin and steroid hormones on the rat prostate in organ culture. Exp. Cell Res. 77 (1973) 111-120
62. Setchell B.P., and Brooks P.E. Anatomy, vasculature. Innervation, and fluids of the male reproductive tract. In: Knobil E., and Neill J. (Eds). The Physiology of Reproduction (1988), Raven Press, New York 753-836
63. Shirai H., Sato T., Hara T., and Minagi S. The effect of diabetes mellitus on histopathological changes in the tissues under denture base and without mechanical pressure. J. Oral Rehabil. 5 (1998) 715-720
64. Sohn B.H., Moon H.B., Kim T.Y., Kang H.S., Bae Y.S., Lee K.K., and Kim S.J. Interleukin-10 up-regulates tumour-necrosis-factor-alpha-related apoptosis-inducing ligand (TRAIL) gene expression in mammary epithelial cells at the involution stage. Biochem. J. 360 (2001) 31-38
65. Soudamani S., Yuvaraj S., Malini T., and Balasubramanian K. Experimental diabetes has adverse effects on the differentiation of ventral prostate during sexual maturation of rats. Anat. Rec. 287 (2005) 1281-1289
66. Sprando R.L. Perfusion of rat testis through the heart using heparin. In: Russel L.D., Ettilin A.P.S., and Cleeg E.D. (Eds). Histological and Histopathological Evolution of the Testis (1990), Cache River Press, Clearwater 277-280
67. Strange R., Friis R.R., Bemis L.T., and Geske F.J. Programmed cell death during mammary gland involution. Methods Cell Biol. 46 (1995) 355-368
68. Sufrin G., and Scott W.W. Effect of drug-induced diabetes on response accessory sex organs of castrate rats to testosterone proprionate. Urol. Surg. 23 (1972) 534-535
69. Tesone M., Valle L.B.S., Foglia V.G., and Charreau E.H. Endocrine function of the testis in streptozotocin diabetic rats. Acta Physiol. Lat. 26 (1976) 387-394
70. Tesone M., Oliveira-Filho R.M., Valle L.B., Calvo J.C., Baranao J.L., Foglia V.G., and Charreau E.H. Androgen receptors in the diabetic rat. Diabetologia 18 (1980) 385-390
71. Toorians A.W., Kelleher S., Gooren L.J., Jimenez M., and Handelsman D.J. Estimating the contribution of the prostate to blood dihydrotestosterone. J. Clin. Endocrinol. Metab. 88 (2003) 5207-5211
72. Tuxhorn J.A., Ayala G.E., and Rowley D.R. Reactive stroma in prostate cancer progression. J. Urol. 166 (2001) 2472-2483
73. Tuxhorn J.A., Ayala G.E., Smith M.J., Smith V.C., Dang T.D., and Rowley D.R. Reactive stroma in human prostate cancer: induction of myofibroblast phenotype and extracellular matrix remodeling. Clin. Cancer Res. 8 (2002) 2912-2923
74. Untergasser G., Madersbacher S., and Berger P. Benign prostatic hyperplasia: age-related tissue-remodeling. Exp. Gerontol. 40 (2005) 121-128
75. Vilamaior P.S., Felisbino S.L., Taboga S.R., and Carvalho H.F. Collagen fiber reorganization in the rat ventral prostate following androgen deprivation: a possible role for smooth muscle cells. Prostate 45 (2000) 253-258
76. Wang Z.J., Ikeda K., Foster H.E., Weiss R.M., and Latifpour J. Expression and localization of basic fibroblast growth factor in diabetic rat prostate. BJU Int. 85 (2000) 945-952
77. Wang L., Yang J.R., Yang L.Y., Liu Z.T., Rao J.M., and Liu L.F. Expression of Ki-67, Bcl-2, Bax and caspase-3 in benign prostatic hyperplasia combined with prostatitis and their significances. Zhong Nan Da Xue Xue Bao Yi Xue Ban 33 (2008) 222-226
78. Weibel E.R. Stereological principles for morphometry in electron microscopy cytology. Int. Rev. Cytol. 26 (1979) 235-302
79. Weihua Z., Makela S., Andersson L.C., Salmi S., Saji S., Webster J.I., Jensen E.V., Nilsson S., and Gustafsson J.A. A role for estrogen receptor beta in the regulation of growth of the ventral prostate. Proc. Natl. Acad. Sci. 98 (2001) 6330-6335
80. Weihua Z., Warner M., and Gustafsson J.A. Estrogen receptor beta in the prostate. Mol. Cell. Endocrinol. 193 (2002) 1-5
81. Will J.C., Vinicor F., and Calle E.E. Is diabetes mellitus associated with prostate incidence and survival?. Epidemiology 10 (1999) 313-318
82. Wilson J., and Blackwill F. The role of cytokines in the epithelial cancer microenvironment. Semin. Cancer Biol. 12 (2002) 113-120
83. Wong Y.C., Xie W., and Tsao S.W. Structural changes and alteration in expression of TGF-beta1 and its receptors in prostatic intraepithelial neoplasia (PIN) in the ventral prostate of noble rats. Prostate 45 (2000) 289-298
84. Xie W., Wong I.C., and Tsao S.W. Correlation of increased apoptosis and proliferation with development of prostatic intraepithelial neoplasia (PIN) in ventral prostate of the Noble rat. Prostate 44 (2000) 31-39
85. Yamano S., Atkinson J.C., Baum B.J., and Fox P.C. Salivary gland cytokine expression in NOD and normal BALB/c mice. Clin. Immunol. 92 (1999) 265-275
86. Zar J.H. Biostatistical Analysis (1999), Prentice Hall, New Jersey p. 663
87. Zhang Y.H., Nojima S., Nakayama H., Jin Y.L., and Enza H. Characteristics of normal stromal components and their correlation with câncer occurrence in human prostate. Oncol. Rep. 10 (2003) 207-211